THE IVERS PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: K82006 | IVER, SL0 9NU
Showing results 451-500 of 513
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Orlistat | 14 | 1,782 | £427 | -83.0% ▼ |
| Metoclopramide hydrochloride | 14 | 1,289 | £41 | -83.1% ▼ |
| Tapentadol | 14 | 1,456 | £648 | -66.0% ▼ |
| Brimonidine tartrate | 14 | 130 | £55 | -64.9% ▼ |
| Budesonide | 14 | 14 | £142 | -10.0% ▼ |
| 14 | 420 | £132 | -57.4% ▼ | |
| Naloxegol | 13 | 390 | £682 | -5.7% ▼ |
| Zinc oxide | 13 | 438 | £46 | -37.2% ▼ |
| Trimipramine maleate | 13 | 1,456 | £5.3K | -18.4% ▼ |
| Colistimethate sodium | 13 | 780 | £1.4K | +15.0% ▲ |
| Tamsulosin and dutasteride hydrochloride | 13 | 750 | £349 | -62.8% ▼ |
| Vardenafil | 13 | 80 | £148 | -6.9% ▼ |
| Ready to serve 2.4 kcal/ml milkshake higher volume (0913011) | 13 | 92.3K | £561 | -35.7% ▼ |
| Ready to serve preterm infant formula (0913111) | 13 | 83.2K | £940 | +48.1% ▲ |
| Timolol and brimonidine | 13 | 95 | £248 | -7.4% ▼ |
| Brinzolamide and timolol | 13 | 65 | £137 | -65.6% ▼ |
| Erythromycin | 13 | 1,110 | £475 | -4.3% ▼ |
| Other toiletry preparations | 13 | 4,500 | £83 | -69.6% ▼ |
| 13 | 170 | £19 | -65.4% ▼ | |
| 13 | 50 | £277 | -53.3% ▼ | |
| 13 | 130 | £376 | +106.1% ▲ | |
| 13 | 780 | £2.0K | -12.1% ▼ | |
| 13 | 390 | £334 | +97.2% ▲ | |
| 13 | 850 | £77 | -72.5% ▼ | |
| 13 | 922 | £73 | -83.8% ▼ | |
| 13 | 2,123 | £112 | -87.2% ▼ | |
| Oxcarbazepine | 12 | 1,950 | £496 | -57.1% ▼ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 12 | 52.5K | £1.0K | -82.9% ▼ |
| Ketorolac trometamol | 12 | 70 | £64 | +29.3% ▲ |
| Clindamycin/tretinoin | 12 | 690 | £261 | +2.2% ▲ |
| 12 | 345 | £60 | -58.6% ▼ | |
| 12 | 1,800 | £2.9K | -34.8% ▼ | |
| 12 | 360 | £670 | -6.2% ▼ | |
| 12 | 380 | £529 | -5.8% ▼ | |
| Bisacodyl | 11 | 462 | £28 | -91.6% ▼ |
| Phosphates (Rectal) | 11 | 93 | £3.6K | -10.0% ▼ |
| Bempedoic acid/Ezetimibe | 11 | 308 | £579 | -82.0% ▼ |
| Doxycycline monohydrate | 11 | 452 | £247 | +1.3% vs avg |
| Erythromycin ethylsuccinate | 11 | 1,496 | £199 | -52.9% ▼ |
| Canagliflozin | 11 | 660 | £819 | -92.3% ▼ |
| Denosumab | 11 | 11 | £2.0K | -59.6% ▼ |
| Timolol and travoprost | 11 | 55 | £206 | -66.0% ▼ |
| 11 | 70 | £144 | -6.7% ▼ | |
| 11 | 1,050 | £121 | -38.1% ▼ | |
| 11 | 1,160 | £4.1K | -54.8% ▼ | |
| 11 | 560 | £2.9K | +30.3% ▲ | |
| Sulfasalazine | 10 | 1,456 | £366 | -92.3% ▼ |
| Sodium citrate (Rectal) | 10 | 110 | £72 | -27.5% ▼ |
| Labetalol hydrochloride | 10 | 1,008 | £93 | -56.0% ▼ |
| Sotalol hydrochloride | 10 | 952 | £26 | -85.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.